ATE306672T1 - Stabilisierte wässerige steroidimmunteststandarten mit cyclodextrins - Google Patents

Stabilisierte wässerige steroidimmunteststandarten mit cyclodextrins

Info

Publication number
ATE306672T1
ATE306672T1 AT96928012T AT96928012T ATE306672T1 AT E306672 T1 ATE306672 T1 AT E306672T1 AT 96928012 T AT96928012 T AT 96928012T AT 96928012 T AT96928012 T AT 96928012T AT E306672 T1 ATE306672 T1 AT E306672T1
Authority
AT
Austria
Prior art keywords
steroide
cyclodextrins
stabilized aqueous
test standards
immune test
Prior art date
Application number
AT96928012T
Other languages
English (en)
Inventor
Gregg T Williams
William R Groskopf
Beimar N Iriarte
Lester A Mitscher
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE306672T1 publication Critical patent/ATE306672T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/14—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar alpha-D-Glucans, i.e. having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan
    • G01N2400/18—Cyclodextrin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT96928012T 1995-07-27 1996-07-23 Stabilisierte wässerige steroidimmunteststandarten mit cyclodextrins ATE306672T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/507,958 US5679573A (en) 1995-07-27 1995-07-27 Stabilized aqueous steroid immunoassay standards with cyclodextrins
PCT/US1996/012090 WO1997005491A1 (en) 1995-07-27 1996-07-23 Stabilized aqueous steroid immunoassay standards with cyclodextrins

Publications (1)

Publication Number Publication Date
ATE306672T1 true ATE306672T1 (de) 2005-10-15

Family

ID=24020795

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928012T ATE306672T1 (de) 1995-07-27 1996-07-23 Stabilisierte wässerige steroidimmunteststandarten mit cyclodextrins

Country Status (8)

Country Link
US (1) US5679573A (de)
EP (1) EP0842435B1 (de)
JP (1) JP3787161B2 (de)
AT (1) ATE306672T1 (de)
CA (1) CA2227532C (de)
DE (1) DE69635275T2 (de)
ES (1) ES2253755T3 (de)
WO (1) WO1997005491A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10032290C2 (de) * 2000-07-03 2002-05-08 Roche Diagnostics Gmbh Adsorptionsmittelhaltige Kontrollflüssigkeit
EP2130023B1 (de) * 2007-03-15 2015-05-06 Ventana Medical Systems, Inc. Stabilisiertes hämatoxylin
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
WO2017002751A1 (ja) * 2015-06-29 2017-01-05 富士レビオ株式会社 甲状腺ホルモン類標準液
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11604199B2 (en) 2017-11-17 2023-03-14 Fujirebio Inc. Treatment liquid for exclusion of steroid included in cyclodextrin

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
JPS60200167A (ja) * 1984-03-24 1985-10-09 Toyobo Co Ltd 化学発光法による過酸化水素の定量法
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4883785A (en) * 1984-07-27 1989-11-28 Chow Wing Sun Complex of anti-fungal agent and cyclodextrin and method
US4870060A (en) * 1985-03-15 1989-09-26 Janssen Pharmaceutica Derivatives of γ-cylodextrin
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
JPS6312025A (ja) * 1987-02-06 1988-01-19 Hitachi Ltd 加減算装置
US4956274A (en) * 1987-04-06 1990-09-11 Microgenics Corporation Reagent stabilization in enzyme-donor and acceptor assay
US4877774A (en) * 1987-09-09 1989-10-31 The United States Of America As Represented By The Department Of Health And Human Services Administration of steroid hormones
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
NL8801670A (nl) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5229370A (en) * 1988-08-15 1993-07-20 Ammeraal Robert N Water soluble branched beta cyclodextrin steroid complex
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
US5068227A (en) * 1989-01-18 1991-11-26 Cyclex, Inc. Cyclodextrins as carriers
US5182270A (en) * 1989-08-03 1993-01-26 Iolab Corporation Stabilizing preparation for thymoxamine
US5328846A (en) * 1989-08-03 1994-07-12 The Penn State Research Foundation Method for removing exogenous deposits from hydrophilic contact lenses
WO1991005605A1 (en) * 1989-10-10 1991-05-02 Kosak Kenneth M Cyclodextrin labels for immunoassay and biochemical analysis
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation

Also Published As

Publication number Publication date
DE69635275T2 (de) 2006-07-20
JPH11510598A (ja) 1999-09-14
ES2253755T3 (es) 2006-06-01
WO1997005491A1 (en) 1997-02-13
US5679573A (en) 1997-10-21
CA2227532A1 (en) 1997-02-13
DE69635275D1 (de) 2006-02-23
EP0842435B1 (de) 2005-10-12
EP0842435A1 (de) 1998-05-20
JP3787161B2 (ja) 2006-06-21
CA2227532C (en) 2009-05-26

Similar Documents

Publication Publication Date Title
DE69635275D1 (de) Stabilisierte wässerige steroidimmunteststandarten mit cyclodextrins
ES8504789A1 (es) Procedimiento para la preparacion de compuestos complejos de piroxicam con ciclodestrinas
EP0693079A4 (de) Derivate von triterpenoid-säuren und ihre verwendung
BE853227A (fr) 11alpha-amino, delta 4 ou delta 5 pregnanes et androstanes a groupe disubstitue
ATE217325T1 (de) Cyclodextrinderivate mit erhöhter wasserlösichkeit und deren verwendung
PT986403E (pt) Composicao com um tempo de vida de armazenagem prolongado compreendendo a ciclodextrina e drogas ou prodrogas que se decompoem em compostos insoluveis em agua
DE58907885D1 (de) Benzimidazol-2-carbonsäureanilide, ihre Verwendung als Lichtschutzmittel für organisches Material und mit diesen Aniliden stabilisiertes organisches Material.
DE59510597D1 (de) 3-aryl-tetronsäure-derivate, deren herstellung und deren verwendung als schädlingsbekämpfungsmittel
ATE104325T1 (de) Waessrige ueberzugsmasse, deren herstellung und verwendung.
ATE1019T1 (de) Hyaluronidase und seine herstellung.
DE3481798D1 (de) Breitbandiger transistorverstaerker mit galvanisch gekoppelten stufen.
IT1243367B (it) Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
ATE378073T1 (de) Von cyclodextrinen stabilisierter radiopharmazeutischer reagenzsatz
PT1165119E (pt) Composicao baseada em polipeptidos com cargas opostas
DE69324949D1 (de) Raucharme Transistorverstärker mit hoher Empfindlichkeit
DE69434356D1 (de) Inclusion-Komplex von Beta-Cyclodextrin mit Diclofenac
ATE159713T1 (de) N-acylglutamin-derivate
FI911758L (fi) Mikro-organismien tunnistaminen mittaamalla entsymaattinen aktiivisuus entsyymiaktiivisuuteen vaikuttavien aineiden läsnäollessa
FI102462B1 (fi) Menetelmä nimesulidin syklodekstriinikompleksin valmistamiseksi
DE60012404D1 (de) Zahnpaste
FI943007L (fi) Syklodekstriiniglykosyylitransferaasit gamma-syklodekstriinin valmistamiseksi
DE69011919D1 (de) Ausgangsstufe für einen Operationsverstärker.
DE69010025D1 (de) Verfahren zur Herstellung von 14-Alpha-hydroxy-4-androsten-3,6,17, trion.
NO870941L (no) Vandige preparater med fytotoksisk virkning.
ITMI910380A1 (it) Composti steroidei attivi sul sistema cardiovascolare

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0842435

Country of ref document: EP

REN Ceased due to non-payment of the annual fee